N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen

C78H122N22O4S4 — CID 158173870

IUPACN-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen
SMILESCCC(=O)Nc1ccc(Sc2nc(N=C(N)C=C(C)N)cc(N3CCC(O)(C(C)C)CC3)n2)cc1.CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCC(N4[C@H](C)CC[C@H]4C)CC3)n2)cc1.Cc1cnc(Nc2cc(N3CC4CCCNC4C3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C28H38N8OS.C25H35N7O2S.C25H29N7OS2.10H2/c1-5-27(37)29-21-8-10-23(11-9-21)38-28-31-24(30-25-16-18(2)33-34-25)17-26(32-28)35-14-12-22(13-15-35)36-19(3)6-7-20(36)4;1-5-23(33)28-18-6-8-19(9-7-18)35-24-30-21(29-20(27)14-17(4)26)15-22(31-24)32-12-10-25(34,11-13-32)16(2)3;1-15-12-27-24(34-15)29-21-11-22(32-13-17-3-2-10-26-20(17)14-32)31-25(30-21)35-19-8-6-18(7-9-19)28-23(33)16-4-5-16;;;;;;;;;;/h8-11,16-17,19-20,22H,5-7,12-15H2,1-4H3,(H,29,37)(H2,30,31,32,33,34);6-9,14-16,34H,5,10-13,26H2,1-4H3,(H,28,33)(H2,27,29,30,31);6-9,11-12,16-17,20,26H,2-5,10,13-14H2,1H3,(H,28,33)(H,27,29,30,31);10*1H/t19-,20-;;;;;;;;;;;;/m1............/s1
InChIKeySGUPTQWEXFUYPT-CLZKGHRLSA-N
MW1560.25 g/mol
LogP16.54
Rot. Bonds23

About N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen

N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen (PubChem CID 158173870) has the molecular formula C78H122N22O4S4 and a molecular weight of 1560.25 g/mol. Its IUPAC name is N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen.

Molecular Properties

Compound NameN-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen
PubChem CID158173870
Molecular FormulaC78H122N22O4S4
Molecular Weight1560.25 g/mol
Exact Mass1558.89
IUPAC NameN-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen
SMILESCCC(=O)Nc1ccc(Sc2nc(N=C(N)C=C(C)N)cc(N3CCC(O)(C(C)C)CC3)n2)cc1.CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCC(N4[C@H](C)CC[C@H]4C)CC3)n2)cc1.Cc1cnc(Nc2cc(N3CC4CCCNC4C3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C28H38N8OS.C25H35N7O2S.C25H29N7OS2.10H2/c1-5-27(37)29-21-8-10-23(11-9-21)38-28-31-24(30-25-16-18(2)33-34-25)17-26(32-28)35-14-12-22(13-15-35)36-19(3)6-7-20(36)4;1-5-23(33)28-18-6-8-19(9-7-18)35-24-30-21(29-20(27)14-17(4)26)15-22(31-24)32-12-10-25(34,11-13-32)16(2)3;1-15-12-27-24(34-15)29-21-11-22(32-13-17-3-2-10-26-20(17)14-32)31-25(30-21)35-19-8-6-18(7-9-19)28-23(33)16-4-5-16;;;;;;;;;;/h8-11,16-17,19-20,22H,5-7,12-15H2,1-4H3,(H,29,37)(H2,30,31,32,33,34);6-9,14-16,34H,5,10-13,26H2,1-4H3,(H,28,33)(H2,27,29,30,31);6-9,11-12,16-17,20,26H,2-5,10,13-14H2,1H3,(H,28,33)(H,27,29,30,31);10*1H/t19-,20-;;;;;;;;;;;;/m1............/s1
InChIKeySGUPTQWEXFUYPT-CLZKGHRLSA-N
XLogP16.54
TPSA339.89 Ų
H-Bond Donors10
H-Bond Acceptors25
Rotatable Bonds23
Heavy Atoms108
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001560.25
LogP ≤ 516.54
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen?
The IUPAC name of N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen (CID 158173870) is N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen.
What is the SMILES notation for N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen?
The canonical SMILES for N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen is CCC(=O)Nc1ccc(Sc2nc(N=C(N)C=C(C)N)cc(N3CCC(O)(C(C)C)CC3)n2)cc1.CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCC(N4[C@H](C)CC[C@H]4C)CC3)n2)cc1.Cc1cnc(Nc2cc(N3CC4CCCNC4C3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)s1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen?
The InChIKey is SGUPTQWEXFUYPT-CLZKGHRLSA-N. The full InChI is InChI=1S/C28H38N8OS.C25H35N7O2S.C25H29N7OS2.10H2/c1-5-27(37)29-21-8-10-23(11-9-21)38-28-31-24(30-25-16-18(2)33-34-25)17-26(32-28)35-14-12-22(13-15-35)36-19(3)6-7-20(36)4;1-5-23(33)28-18-6-8-19(9-7-18)35-24-30-21(29-20(27)14-17(4)26)15-22(31-24)32-12-10-25(34,11-13-32)16(2)3;1-15-12-27-24(34-15)29-21-11-22(32-13-17-3-2-10-26-20(17)14-32)31-25(30-21)35-19-8-6-18(7-9-19)28-23(33)16-4-5-16;;;;;;;;;;/h8-11,16-17,19-20,22H,5-7,12-15H2,1-4H3,(H,29,37)(H2,30,31,32,33,34);6-9,14-16,34H,5,10-13,26H2,1-4H3,(H,28,33)(H2,27,29,30,31);6-9,11-12,16-17,20,26H,2-5,10,13-14H2,1H3,(H,28,33)(H,27,29,30,31);10*1H/t19-,20-;;;;;;;;;;;;/m1............/s1.
What are the key properties of N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen?
N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen has a molecular weight of 1560.25 g/mol, XLogP of 16.54, 23 rotatable bonds, 10 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[4-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-6-[(5-methyl-1,3-thiazol-2-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide;N-[4-[4-(1,3-diaminobut-2-enylideneamino)-6-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)pyrimidin-2-yl]sulfanylphenyl]propanamide;N-[4-[4-[4-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]piperidin-1-yl]-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide;molecular hydrogen is sourced from PubChem (CID 158173870), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).